Quinidine
Back to searchMolecule Structure
Scientific Name
Quinidine
Description of the Drug
Quinidine is a medication used to restore normal sinus rhythm, treat atrial fibrillation and flutter, and treat ventricular arrhythmias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00908
http://www.drugbank.ca/drugs/DB00908
Brand Name(s)
Not Available
Company Owner(s)
Dava Pharmaceuticals Inc, Scherer Laboratories Inc, Eywa Pharma Inc, Sun Pharmaceutical Industries Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Kv Pharmaceutical Co, Purepac Pharmaceutical Co, Impax Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15943 | SCHEMBL17537608 | |||
| PharmGKB | PA451209 | ||||
| Human Metabolome Database | HMDB0015044 | ||||
| DrugBank | DB00908 | ||||
| PubChem: Thomson Pharma | 14899514 | ||||
| PubChem | 441074 | ||||
| Mcule | MCULE-7178915526 | ||||
| NMRShiftDB | 40248436 | ||||
| LINCS | LSM-46038 | LSM-3325 | |||
| PDBe | QDN | ||||
| BindingDB | 50121975 | ||||
| EPA CompTox Dashboard | DTXSID4023549 | ||||
| DrugCentral | 2346 | ||||
| Metabolights | MTBLC28593 | ||||
| Brenda | 145983 | 229835 | 229836 | 145069 | 4861 |
| Guide to Pharmacology | 2342 | ||||
| rxnorm | QUINIDINE | QUINIDINE GLUCONATE | QUINIDINE SULFATE | ||
| ChEBI | 28593 | ||||
| ZINC | ZINC000003831405 |
